BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10603899)

  • 1. Colorectal cancer. Part 1: Epidemiology, aetiology, screening and diagnosis.
    Campbell T
    Prof Nurse; 1999 Sep; 14(12):869-74. PubMed ID: 10603899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology and screening of colorectal cancer].
    Dancourt V; Faivre J
    Rev Prat; 2004 Jan; 54(2):135-42. PubMed ID: 15086055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colorectal cancer: a risk-adapted screening and the role of the physician in the prevention of this cancer].
    Chappuis PO; Hutter P
    Rev Med Suisse; 2006 May; 2(66):1314, 1316, 1318-23. PubMed ID: 16775992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening.
    Winawer SJ
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1031-48. PubMed ID: 18070702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer in women: an equal opportunity disease.
    Osias GL; Osias KB; Srinivasan R
    J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 2):S7-12. PubMed ID: 11794751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer: prevention and screening.
    Pontieri-Lewis V
    Medsurg Nurs; 2000 Feb; 9(1):9-13, 20; quiz 14-5. PubMed ID: 11000778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass colorectal cancer screening: choosing an effective strategy.
    Burris J; McGovern P
    AAOHN J; 1993 Apr; 41(4):186-91. PubMed ID: 8507285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and screening of colorectal cancer.
    Faivre J; Bouvier AM; Bonithon-Kopp C
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):187-99. PubMed ID: 11969233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for cancer control: colorectal cancer.
    Cox B; Sneyd M
    N Z Med J; 2005 Aug; 118(1221):U1632. PubMed ID: 16138170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for colorectal cancer by endoscopy: rectosigmoidoscopy or coloscopy?].
    Adler M; Demols A; Franchimont D; Van Laethem JL; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A210-3. PubMed ID: 11680175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal carcinoma: is screening possible?
    Bonelli L
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.